IL1B and type 1 diabetes mellitus: iBET-151 and GSK046 significantly protected human β-cells from the pro-inflammatory but not from the pro-apoptotic effects of IFNγ + IL1β (Figures 5, S6, and 7), cytokines that mimic advanced inflammatory features in T1D, present in the later stages of insulitis.10